News       Events               CHITIN

 

Growth in cancer research funding

New figures from the National Cancer Research Institute (NCRI) show that cancer research funding by NCRI partners has reached £700m for the first time, following five years of increased spending.

This increase in cancer research funding was driven by a 9% increase in spend in Early Detection, Diagnosis and Prognosis research. Research into Treatment and Cancer Control, Survivorship, and Outcomes Research received less funding than in previous years.

For more information see NCRI website> https://www.ncri.org.uk/ncri-blog/increase-in-cancer-research-funding/

HSC R&D Division is a partner in NCRI which was set up in 2001 with a mission to bring together all the key players in cancer research in the UK to identify where research is most needed and where it is most likely to contribute to progress.